Document Detail


Valvular dysfunction and venous obstruction in the post-thrombotic syndrome.
MedLine Citation:
PMID:  19303507     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Medical thrombosis physicians have tended to view deep vein thrombosis (DVT) as essentially a problem of biology and hematology. This "field condition" concept holds that in susceptible individuals, DVT risk factors lead to a global hypercoagulable state which results in venous thrombosis. However, less attention has been paid to the key problems of venous anatomy and physiology that lead to the post-thrombotic syndrome (PTS) and its major health consequences. The primary objectives of this article are: (1) to review the macroscopic pathophysiology of PTS; (2) to discuss the roles of valvular reflux and venous obstruction in the development of PTS; and (3) to explore new endovascular PTS prevention and treatment strategies that feature the prevention or elimination of valvular reflux and late venous obstruction to improve DVT patient outcomes.
Authors:
Suresh Vedantham
Related Documents :
10669997 - Electrohydraulic lithotripsy treatment of gallstone after disimpaction of the stone fro...
11942877 - Central anticholinergic syndrome in a child undergoing circumcision.
10189657 - Failure of the laryngeal mask to secure the airway in a patient with hunter's syndrome ...
7434217 - Benign mechanical obstruction of the common hepatic duct (mirizzi syndrome).
11791777 - Horner's syndrome associated with a mandibular symphyseal fracture and bilateral tempor...
22300117 - Recurrent small intestine intussusception in a patient with peutz-jeghers syndrome.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Thrombosis research     Volume:  123 Suppl 4     ISSN:  0049-3848     ISO Abbreviation:  Thromb. Res.     Publication Date:  2009  
Date Detail:
Created Date:  2009-03-23     Completed Date:  2009-07-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S62-5     Citation Subset:  IM    
Affiliation:
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA. vedanthams@mir.wustl.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anticoagulants / therapeutic use
Balloon Dilatation
Combined Modality Therapy
Fibrinolytic Agents / therapeutic use
Humans
Laser Therapy
Postthrombotic Syndrome / pathology,  physiopathology*,  prevention & control,  therapy
Recurrence
Thrombectomy
Thrombolytic Therapy
Treatment Outcome
Venous Thrombosis / pathology,  physiopathology*,  therapy
Venous Valves / pathology,  physiopathology*
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Next Document:  Dermal pathology, cellular biology, and inflammation in chronic venous disease.